

Scientific Presentations
Glycan Therapeutics: Resurrecting an Almost Pharma‐Forgotten Drug Class
Posted on August 24, 2018
Despite their enormous potential, glycans as therapeutics yet remain a widely untapped drug class. This overview shares the viewpoint that glycans have been aptly termed the “dark matter” of biology and have thus been largely ignored for decades. Provided herein is a background on the multiple structures and functions of glycan therapeutics, and focuses on examples and case studies of the glycan therapeutics in clinical use or in a clinical development. Perspectives on various hurdles are also provided, such as regulatory or scientific messaging and how these can influence the clinical development of this drug category. Finally some of the necessary changes in perception, education, and research infrastructure for continued support and advancement of this promising category of therapeutics are described. – Full Article Link
Anti-Fibrotic Effect of SB-030 and Implications for Peripheral Vein Graft Bypass
Posted on March 14, 2018
2018 Keystone Symposium, Vascular Biology and Human Diseases: From Molecular Pathways to Novel Therapeutics, Poster Presentation – PDF Download
Targeting the Vessel Wall During Vascular Intervention with SB-030 Prevents Platelet Activation and Subsequent Neointimal Hyperplasia
Posted on September 21, 2017
ESC (European Society of Cardiology) Congress 2017 Poster Presentation – PDF Download
Sustained Efficacy of Intra-Articular SB-061, a Novel Matrix Regulator Inspired by Aggrecan, in a Rat Model of Osteoarthritis
Posted on March 14, 2018
2017 ACR/ARHP Annual Meeting (American College of Rheumatology) Poster Presentation – PDF Download
Interfering With Local Fibrotic Platelet Activation Significantly Inhibits Fibrosis in Multiple Animal Models
Posted on May 3, 2018
International Liver Congress 2018 “Best of ILC 2018” Summary Slide – PDF Download